Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Halo Coffee (HC) makes 100% home compostable biodegradable coffee capsules. It has sold its products to more than 9,000 customers across 70 countries. The company has generated 45% of sales revenues by subscription customers having a more 40% retention rate. HC was the winner of Sky: Beyond Plastic category at the tve 2019 Global Sustainability Awards. It has also signed a partnership with The Perfect World Foundation, and onboarded noted environmentalist, Sir David Attenborough. HC is the official sponsor of the British Olympic Sailing team. The company is planning to launch Halo Coffee Germany (GmbH) in 2021. The company will use the investment to build brand awareness, further develop sales, drive customer acquisition, expand product portfolio, strengthen the team and build Capsule Generation II.
days to go:
Expired
investment:
£349,160
Infinity Circle (IC) is a digital wealth creation platform that aims to create an ecosystem where wealth management meets social media in a way that is cyber secure, respects a user's privacy, and complies with the Financial Conduct Authority's (FCA) rules. IC intends to vet and distribute the best-in-class products for each asset class on its platform that is planned to be partly automated and partly operated by specialists who can guide a user. IC asserts that its CEO Elisabeth Dana has worked with the likes of Barclays Private Wealth, handling average accounts of £50 million while its CTO, Ashley Adkins, is a coding expert who has put his talent at the service of the UK Government before starting his private practice. It will use 40% of the investment for technology innovation, 30% for upgrading operations, and 30% to market the platform's launch.
days to go:
Expired
investment:
£335,390
DMALINK aims to create a transparent and accessible currency market for banks, funds, and corporations. The company asserts that the Foreign Exchange (FX) market is the world's largest and most liquid financial market, recording an average daily trading volume of $6.6 Trillion but is fraught with imperfect price movements. DMALINK aims to address this situation. Its portal utilises big data and analytics solutions to enable users to make better trading decisions. It also offers users access to 63 currency pair combinations. DMALINK also points out that its clients have chosen its services over 316,000 times with the company witnessing an average deal size of $585,000 and earning revenue worth $3,140,000. The company has featured in Business Insider, Yahoo Finance, and FX Markets to name a few. DMALINK will use 60% of the investment on salaries for existing and new team members allowing global growth, 20% towards marketing and sales efforts, and 20% towards technology expansion.
days to go:
Expired
investment:
£425,903
Gunna Drinks (GD) manufactures and sells craft soft drinks, consisting of natural juices with less than 5% sugar having zero artificial colours or flavours. The company asserts that it has outshone established competitors like Gingerella, Fentimans and FeverTree in taste tests. GD is stocked in major supermarkets and convenience stores across the UK such as Co-ops, Sainsbury’s, Amazon, Ocado, and JD Wetherspoon. The company won the prestigious 'Great Taste Award' in 2020 and witnessed more than doubled revenues in 2018-2020, with a 23% growth in 2020 despite COVID. The company will utilise the investment to boost consumer advertising to accelerate the growth of its online store, focus on trade investment to further increase the rate of sale, and concentrate on New Product Development (NPD).
days to go:
Expired
investment:
£696,261
Bambooloo is a sustainable consumer products company that creates, manufactures, and sells earth-friendly, modern brands. It has set up its base of operations in Singapore and is endeavouring to enter the UK market soon. Bambooloo launched to high acclaim both online and offline in Singapore with its 100% plastic free packaging product line. It is now on the verge of launching its other product lines; The Nurturing Co-brand focused on care and cleaning products with zero one time use plastics; and Wipeless, an environmentally focused bidet brand. Bambooloo argues that the global hygiene paper sector alone is valued at over $84 billion per year. It aims to be a segment leader in this sector. Bambooloo was the inaugural winner of the Sustainable Business Award Winner 2019. The company will use the investment to establish a beachhead business in the UK, hire internal and external teams for marketing, and set up its website for procuring more orders.
days to go:
Expired
investment:
£187,013
